MUC1 and neoplasm: Jude Children's Research Hospital, Memphis, Tennessee) for providing the SJ-ACC3 tumor model and Guillaume Assie and Jérôme Bertherat (INSERM U1016, Institut Cochin, Paris, France) for providing the information about the mutational status of MUC-1.